Read More Pharma Industry News Alphamab Oncology enrols patients for KN026-203 phase 2 clinical trial Alphamab Oncology said that it has completed enrolling patients in China for its KN026-203 phase 2 clinical trial… bySrinathJanuary 15, 2022
